-
Two-year Outcomes of Rapid Eye Movement Behavior Disorder Following Globus Pallidus Interna Deep Brain Stimulation for Parkinson’s Disease
-
Two-year Outcomes of Restless Legs Syndrome Following Globus Pallidus Interna Deep Brain Stimulation for Parkinson’s Disease
-
Type 1 Diabetes and Risk of Parkinson’s Disease: A Nationwide Nested Case–Control Study
-
Ulixacaltamide Demonstrates Broad Functional Improvement Across Individual Domains of Activities of Daily Living in Essential Tremor
-
Ulixacaltamide Demonstrates Superiority Over Placebo as Monotherapy and as Add-on to Propranolol in Essential Tremor: Phase 3 ESSENTIAL3 Study 1
-
Ultra-early Diagnosis of MSA-C Using Biological Biomarkers: A Two-Case Study Employing α-Synuclein PET and Fluid α-Synuclein Seeds Amplification Assay (SAA)
-
Uncovering novel genomic alterations in dystonia using gene burden analysis
-
Uncovering Parkinson Disease Progression Biomarkers with Plasma Proteomics and Functional Genomics
-
Uncovering Sleep Neural Signatures of Parkinson’s Disease and REM Sleep Behavior Disorder from Polysomnography through Interpretable Deep Learning
-
Underestimation of Nighttime Sleep Symptoms in Isolated RBD is Associated with Increased Risk of Phenoconversion to Synucleinopathy: A North American Prodromal Synucleinopathy Consortium Study
- « Previous Page
- 1
- …
- 199
- 200
- 201
- 202
- 203
- …
- 208
- Next Page »
